<DOC>
	<DOCNO>NCT02466412</DOCNO>
	<brief_summary>The primary objective clinical study evaluate pharmacokinetic ( PK ) profile nicotine ( rate amount nicotine absorb ) single use Carbon Heated Tobacco Product 1.1 Menthol ( CHTP 1.1 M ) compare menthol conventional cigarette ( mCC ) healthy smoker .</brief_summary>
	<brief_title>Nicotine Pharmacokinetic Profile CHTP 1.1 M</brief_title>
	<detailed_description />
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Menthol</mesh_term>
	<criteria>Subject Japanese . Subject minimum 23 year age . Smoking , healthy subject judge Investigator . Subject smoke least last 3 year Subject smoke least 10 commercially available mCCs per day last 4 week . As per Investigator judgment , subject participate study reason ( e.g. , medical , psychiatric , and/or social reason ) . Subject received medication within 14 day within 5 halflives drug ( whichever longer ) impact CYP2A6 activity . Female subject pregnant breast feeding . Female subject agree use acceptable method effective contraception .</criteria>
	<gender>All</gender>
	<minimum_age>23 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>smoking</keyword>
	<keyword>nicotine absorption</keyword>
	<keyword>modify risk tobacco product</keyword>
	<keyword>conventional cigarette</keyword>
	<keyword>Carbon Heated Tobacco Product</keyword>
</DOC>